Abstract
Objective
Human vascular smooth muscle cells (VSMC) prepared by enzyme dispersal have been reported to proliferate more slowly and remain more differentiated than VSMC derived by explant culture. The aim of this study was to investigate whether these differences are attributable to the production of transforming growth factor beta (TGF beta), a major modulator of VSMC properties in culture, by enzyme dispersal, but not explant, cultures.Methods
Human aortic VSMC cultures were prepared by enzymatic dissociation of aortic media or by outgrowth of cells from explants derived from the vessel media. Properties, including rate of proliferation and differentiation, of the two different types of culture obtained from 10 donors (age 3-54 years, of either sex) were compared. The role of TGF beta as mediator of these differences was investigated.Results
VSMC from enzyme dispersal cultures proliferated with a long doubling time in 20% fetal calf serum of 68(SEM 2) h, reaching a low saturation density with no "hills and valleys", and the cells were predominantly of stellate morphology. VSMC from explant cultures proliferated with a shorter doubling time of 35(2) h, reached a higher saturation density with "hills and valleys", and showed a spindle shaped morphology. The enzyme dispersed cells, but not the explant cells, released TGF beta into the medium. Addition of exogenous TGF beta to the explant cells extended the doubling time, while addition of a neutralising antibody to the enzyme dispersed cells decreased the doubling time. Tamoxifen, an anti-oestrogenic drug, decreased the rate of proliferation of the explant cells (ED50 = 50 nM; n = 3) but not enzyme dispersed cells by stimulating production of TGF beta. The explant and enzyme dispersal cultures also differed in response to growth factors. The explant cultures stimulated DNA synthesis in response to platelet derived growth factor (PDGF) AA and BB. Enzyme dispersal cultures stimulated DNA synthesis in response to PDGF-BB but response to AA was weaker and also variable.Conclusions
Human explant derived VSMC systematically differ from enzyme dispersed VSMC obtained from the same donor tissue. Wherever the potential role of TGF beta was investigated, the differences between enzyme dispersal and explant cultures were due to autocrine production of TGF beta by the enzyme dispersal, but not explant cultures.Citations & impact
Impact metrics
Article citations
Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions.
Am J Physiol Cell Physiol, 322(1):C73-C85, 24 Nov 2021
Cited by: 7 articles | PMID: 34817269 | PMCID: PMC8791793
A novel method to obtain rat aortic media for primary culture of rat aortic smooth muscle cells.
In Vitro Cell Dev Biol Anim, 57(7):726-734, 30 Aug 2021
Cited by: 2 articles | PMID: 34462813
Regulation of renal fibrosis by Smad3 Thr388 phosphorylation.
Am J Pathol, 184(4):944-952, 30 Jan 2014
Cited by: 20 articles | PMID: 24485922
A comparison of human smooth muscle and mesenchymal stem cells as potential cell sources for tissue-engineered vascular patches.
Tissue Eng Part A, 18(9-10):986-998, 26 Jan 2012
Cited by: 13 articles | PMID: 22145703
Relationship between lipoprotein(a) concentrations and intima-media thickness: a healthy population study.
Eur J Prev Cardiol, 19(6):1290-1295, 13 Sep 2011
Cited by: 11 articles | PMID: 21914687
Go to all (27) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Pentoxifylline inhibits PDGF-induced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells.
J Mol Cell Cardiol, 31(4):773-783, 01 Apr 1999
Cited by: 37 articles | PMID: 10329205
Differential response of mesoderm- and neural crest-derived smooth muscle to TGF-beta1: regulation of c-myb and alpha1 (I) procollagen genes.
Exp Cell Res, 230(2):169-180, 01 Feb 1997
Cited by: 66 articles | PMID: 9024776
Platelets, growth factors, and vascular smooth-muscle cells in hypertension and diabetes.
J Cardiovasc Pharmacol, 22 Suppl 6:S64-74, 01 Jan 1993
Cited by: 14 articles | PMID: 7508064
Review
Funding
Funders who supported this work.